Skip to main content

Table 1 Clinical, ECG, and metabolic details of patients in the study (controls and patients undergoing surgery).

From: Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters

 

CONTROLS

  

SURGERY

  

BEFORE

AFTER

CHANGE

BEFORE

AFTER

CHANGE

N (men, women)

37 (5/32)

  

101 (17/84)

  

Age (y)

46.5 ± 2.07

  

44.8 ± 0.98

  

Interval (mos)

59.3 ± 4.44

  

65.4 ± 4.65

  

BMI (kg/m2)

43.8 ± 1.18

43.5 ± 1.54

+0.3 ± 0.81

45.7 ± 0.67

34.2 ± 0.59 #

-11.1 ± 0.71 #

Systolic BP (mmHg)

133.5 ± 2.39

140.5 ± 3.12

+7.0 ± 3.82

136.4 ± 1.65

127.1 ± 1.48 #

-9.4 ± 1.95 #

Diastolic BP (mmHg)

83.7 ± 1.52

89.4 ± 1.91

+5.8 ± 2.46

85.9 ± 1.34

81.1 ± 1.01 #

-4.7 ± 1.53 #

Hypertension (y/n)

14/23

21/16

+7 (-3, +10)

40/61

20/81 #

-20 (-23, +3) §

Heart rate (bpm)

74.9 ± 1.83

74.2 ± 1.84

-0.6 ± 2.31

80.4 ± 1.29 *

67.5 ± 0.98 #

-12.9 ± 1.24 #

QTc (msec)

412.8 ± 4.62

410.7 ± 4.88

-2.1 ± 5.41

412.4 ± 2.99

398.7 ± 2.81 *

-13.7 ± 3.03 *

Cornell-voltage (mm.ms)

1487.3 ± 84.75

1434.6 ± 81.64

-52.7 ± 62.43

1561.1 ± 57.77

1461.3 ± 57.39

-106.1 ± 59.44

RPP

99.7 ± 2.99

104.7 ± 3.91

+5.6 ± 4.43

109.7 ± 2.39 *

86.2 ± 1.58 #

-23.6 ± 2.42 #

LVH (y/n) °

8/29

5/32

-3 (+2, -5)

31/70

28/73

-3 (+9, -12)

Cholesterol (mg/dl)

195.4 ± 8.66

198.9 ± 6.88

+2.1 ± 5.17

203.5 ± 4.47

183.5 ± 5.82

-20.4 ± 6.55 *

Triglycerides (mg/dl)

114.1 ± 8.57

123.9 ± 8.96

+9.4 ± 8.04

162.4 ± 17.13

100.3 ± 5.84 *

-64.1 ± 17.14 *

Blood glucose (mg/dl)

117.7 ± 8.74

124.6 ± 9.63

+6.9 ± 6.77

106.2 ± 3.58

91.1 ± 1.91 #

-15.1 ± 3.18 **

Diabetes mellitus (y/n)

9/28

11/26

+2

14/87

4/97 #

-10 *

Metabolic Syndrome (y/n)

15/22

13/24

-2 (-6, +4)

30/71

11/90 **

-19 *

  1. Means ± SE or absolute frequencies
  2. ° as defined by ECG criteria
  3. * = p < 0.05; ** = p < 0.01; # = p < 0.001 vs corresponding values of controls